Economic evaluation of betibeglogene autotemcel (Beti-cel) gene addition therapy in transfusion-dependent β-thalassemia
Background Standard of care (SoC) for transfusion-dependent β-thalassemia (TDT) requires lifelong, regular blood transfusions as well as chelation to reduce iron accumulation. Objective This study investigates the cost-effectiveness of betibeglogene autotemcel (‘beti-cel’; LentiGlobin for β-thalasse...
Na minha lista:
| Principais autores: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI AG
2021-01-01
|
| Serier: | Journal of Market Access & Health Policy |
| Fag: | |
| Online adgang: | http://dx.doi.org/10.1080/20016689.2021.1922028 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|
